RecruitingPhase 4NCT06433310
Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study
Sponsor
Weill Medical College of Cornell University
Enrollment
20 participants
Start Date
Oct 17, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to explore how the dietary supplement L-Phenylalanine affects the production of the metabolite phenylpropionic acid (PPA) and changes fungal populations of the gut microbiome.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called L-Phenylalanine 500 mg Veg Capsule product for people with dietary supplement, gut microbiome, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGL-Phenylalanine 500 mg Veg Capsule product
500 mg Veg Capsule product
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06433310
Related Trials
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
NCT066911001 location
Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure
NCT067355991 location
GBPDC: Gut-Brain in PD Consortium Master Protocol
NCT075677947 locations
Effects of Probiotic Supplementation on Gut Health, Immune Response, and Well-Being
NCT07779265
The Gut Microbiome and Serum Metabolites as a Biological Mechanism Underlying Pain in Kidney Transplantation
NCT062064861 location